Department of Immunology, Beckman Research Institute, City of Hope, 1450 E. Duarte Road, Duarte, CA 91010-3000, USA.
Exp Biol Med (Maywood). 2010 Dec;235(12):1450-63. doi: 10.1258/ebm.2010.010056.
Activation of T lymphoma cells expressing Syk, but not ZAP-70 tyrosine kinase, has been shown to negatively regulate cell activation and activation-induced cell death (AICD), perhaps due to differential induction of tyrosine phosphorylation modified proteins. To better understand the role of these proteins and their associated molecules/pathways, we studied a previously described model of T lymphoma cells expressing either a kinase-activated chimeric Syk or ZAP-70 genetically linked to T-cell receptor (TCR) ζ chain (Z/Syk or Z/ZAP cells, respectively). To help identify molecules and pathways linked to cell activation or AICD, a comparative semi-quantitative proteomics-based approach was utilized to analyze tyrosine-phosphorylated protein immunoprecipitates from two-minute short-term activated Z/Syk or Z/ZAP cells. Using the resulting bioinformatics data-sets, we identified several differentially immunoprecipitated proteins that could be validated biochemically. More tyrosine-phosphorylated and phosphotyrosine-associated proteins were found in Z/Syk than in Z/ZAP cells. Proteins involved in different unique functional pathways were induced in these cells and showed altered intermolecular interactions in varied pathways. Remarkably, 41% of differentially identified proteins in Z/Syk cells belonged to cell cycle or vesicle/trafficking pathways. In contrast, 21% of such proteins in Z/ZAP cells belonged to metabolism pathways. Therefore, molecular pathways involved in post-translational modifications linked to distinct cellular/physiological functions are differentially activated, which may contribute to varied activation and AICD responses of these cells. In summary, we identified proteins belonging to novel differentially activated pathways involved in TCR-mediated signaling, which may be targets for regulating activation and AICD of T lymphoma cells and for potential cancer therapy.
已证实,表达 Syk 但不表达 ZAP-70 酪氨酸激酶的 T 淋巴瘤细胞的激活可负调控细胞激活和激活诱导的细胞死亡(AICD),这可能是由于差异诱导了酪氨酸磷酸化修饰蛋白。为了更好地理解这些蛋白及其相关分子/途径的作用,我们研究了先前描述的表达激酶激活嵌合 Syk 或 ZAP-70 的 T 淋巴瘤细胞模型,这些蛋白与 T 细胞受体(TCR)ζ 链(分别为 Z/Syk 或 Z/ZAP 细胞)在遗传上相连。为了帮助识别与细胞激活或 AICD 相关的分子和途径,我们利用基于半定量蛋白质组学的比较方法分析了在两分钟的短期激活的 Z/Syk 或 Z/ZAP 细胞中免疫沉淀的酪氨酸磷酸化蛋白。使用由此产生的生物信息学数据集,我们鉴定了一些可通过生化方法验证的差异免疫沉淀蛋白。在 Z/Syk 细胞中发现了更多的酪氨酸磷酸化和磷酸酪氨酸相关蛋白。这些细胞中诱导了不同的独特功能途径中的蛋白,并显示出不同途径中分子间相互作用的改变。值得注意的是,在 Z/Syk 细胞中,41%的差异鉴定蛋白属于细胞周期或囊泡/运输途径。相比之下,在 Z/ZAP 细胞中,有 21%的差异鉴定蛋白属于代谢途径。因此,与不同细胞/生理功能相关的翻译后修饰涉及的分子途径被差异激活,这可能导致这些细胞的激活和 AICD 反应不同。总之,我们鉴定了属于 TCR 介导的信号转导中涉及的新型差异激活途径的蛋白,这些蛋白可能是调节 T 淋巴瘤细胞激活和 AICD 的靶点,并可能用于癌症治疗。